{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T20:01:08Z","timestamp":1769630468255,"version":"3.49.0"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["61972138"],"award-info":[{"award-number":["61972138"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>In the past few decades, chronic hepatitis B caused by hepatitis B virus (HBV) has been one of the most serious diseases to human health. The development of innovative systems is essential for preventing the complex pathogenesis of hepatitis B and reducing side effects caused by drugs. HBV inhibitory drugs have been developed through various compounds, and they are often limited by routine experimental screening and delay drug development. More recently, virtual screening of compounds has gradually been used in drug research with strong computational capability and is further applied in anti-HBV drug screening, thus facilitating a reliable drug screening process. However, the lack of structural information in traditional compound analysis is an important hurdle for unsatisfactory efficiency in drug screening. Here, a natural language processing technique was adopted to analyze compound simplified molecular input line entry system strings. By using the targeted optimized word2vec model for pretraining, we can accurately represent the relationship between the compound and its substructure. The machine learning model based on training results can effectively predict the inhibitory effect of compounds on HBV and liver toxicity. The reliability of the model is verified by the results of wet-lab experiments. In addition, a tool has been published to predict potential compounds. Hence, this article provides a new perspective on the prediction of compound properties for anti-HBV drugs that can help improve hepatitis B diagnosis and further develop human health in the future.<\/jats:p>","DOI":"10.1093\/bib\/bbab593","type":"journal-article","created":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T12:07:15Z","timestamp":1640347635000},"source":"Crossref","is-referenced-by-count":23,"title":["S2DV: converting SMILES to a drug vector for predicting the activity of anti-HBV small molecules"],"prefix":"10.1093","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5883-1016","authenticated-orcid":false,"given":"Jinsong","family":"Shao","sequence":"first","affiliation":[{"name":"School of Public Health, Nantong University"}]},{"given":"Qineng","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, School of Pharmacy, Fudan University"}]},{"given":"Zeyu","family":"Yin","sequence":"additional","affiliation":[{"name":"School of Information Science and Technology, Nantong University, Nantong, China"}]},{"given":"Wenjie","family":"Pan","sequence":"additional","affiliation":[{"name":"department of medical informatics, Nantong University"}]},{"given":"Sanjeevi","family":"Pandiyan","sequence":"additional","affiliation":[{"name":"Intelligence Information Technology, Nantong University"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[{"name":"Intelligence Information Technology, Nantong University"}]}],"member":"286","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"issue":"10003","key":"2022031506300914700_ref1","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013","volume":"386","author":"Schweitzer","year":"2015","journal-title":"The Lancet"},{"issue":"8","key":"2022031506300914700_ref2","doi-asserted-by":"crossref","first-page":"e00560","DOI":"10.1128\/AAC.00560-17","article-title":"Capsid assembly modulators have a dual mechanism of action in primary human hepatocytes infected with hepatitis B virus","volume":"61","author":"Berke","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"2022031506300914700_ref3","doi-asserted-by":"crossref","first-page":"914","DOI":"10.4103\/0366-6999.204107","article-title":"Efficacy and safety of Tenofovir disoproxil treatment for chronic hepatitis B patients with genotypic resistance to other nucleoside analogues: a prospective study","volume":"130","author":"Zhou","year":"2017","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"2022031506300914700_ref4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S1473-3099(15)00218-2","article-title":"Seroepidemiology of hepatitis B virus infection in 2 million men aged 21-49 years in rural China: a population-based, cross-sectional study","volume":"16","author":"Liu","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"2022031506300914700_ref5","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1097\/TP.0000000000001883","article-title":"Oral Nucleos(t)ide Analogs alone after liver transplantation in chronic hepatitis B with preexisting rt204 mutation","volume":"101","author":"Fung","year":"2017","journal-title":"Transplantation"},{"issue":"1","key":"2022031506300914700_ref6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/hep.31008","article-title":"RNA interference therapy with ARC-520 results in prolonged hepatitis B surface antigen response in patients with chronic hepatitis B infection","volume":"72","author":"Yuen","year":"2020","journal-title":"Hepatology"},{"key":"2022031506300914700_ref7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.antiviral.2015.06.019","article-title":"Synthetic RNAi triggers and their use in chronic hepatitis B therapies with curative intent","volume":"121","author":"Gish","year":"2015","journal-title":"Antiviral Res"},{"issue":"4","key":"2022031506300914700_ref8","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.cell.2009.01.035","article-title":"Origins and mechanisms of miRNAs and siRNAs","volume":"136","author":"Carthew","year":"2009","journal-title":"Cell"},{"issue":"11","key":"2022031506300914700_ref9","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.2165\/00003495-200565110-00001","article-title":"Drugs in development for hepatitis B","volume":"65","author":"Buti","year":"2005","journal-title":"Drugs"},{"issue":"2","key":"2022031506300914700_ref10","first-page":"215","article-title":"Approaches to antiviral drug development","volume":"62","author":"Prusoff","year":"1989","journal-title":"Yale J Biol Med"},{"issue":"4","key":"2022031506300914700_ref11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/oxfordjournals.bmb.a072069","article-title":"A history of the discovery and clinical application of antiviral drugs","volume":"41","author":"Bauer","year":"1985","journal-title":"Br Med Bull"},{"issue":"1","key":"2022031506300914700_ref12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/1469-0691.12056","article-title":"Next-generation sequencing technology in clinical virology","volume":"19","author":"Capobianchi","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"2022031506300914700_ref13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1758-2946-6-13","article-title":"TCMSP: a database of systems pharmacology for drug discovery from herbal medicines","volume":"6","author":"Ru","year":"2014","journal-title":"J Chem"},{"key":"2022031506300914700_ref14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-540-79086-0_1","article-title":"Antiviral strategies","volume":"189","author":"M\u00fcller","year":"2009","journal-title":"Antiviral Strategies"},{"issue":"2","key":"2022031506300914700_ref15","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.taap.2010.10.017","article-title":"SAR\/QSAR methods in public health practice","volume":"254","author":"Demchuk","year":"2011","journal-title":"Toxicol Appl Pharmacol"},{"issue":"10","key":"2022031506300914700_ref16","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/jcc.21804","article-title":"Ensemble QSAR: a QSAR method based on conformational ensembles and metric descriptors","volume":"32","author":"Pissurlenkar","year":"2011","journal-title":"J Comput Chem"},{"issue":"1","key":"2022031506300914700_ref17","first-page":"1","article-title":"QSAR DataBank-an approach for the digital organization and archiving of QSAR model information","volume":"6","author":"Ruusmann","year":"2014","journal-title":"J Chem"},{"issue":"24","key":"2022031506300914700_ref18","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.2174\/138161210792389234","article-title":"Predicting drugs and proteins in parasite infections with topological indices of complex networks: theoretical backgrounds, applications and legal issues","volume":"16","author":"Gonzalez-Diaz","year":"2010","journal-title":"Curr Pharm Des"},{"issue":"2","key":"2022031506300914700_ref19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.aca.2009.08.022","article-title":"Multi-target spectral moment: QSAR for antiviral drugs vs. different viral species","volume":"651","author":"Prado-Prado","year":"2009","journal-title":"Anal Chim Acta"},{"issue":"1","key":"2022031506300914700_ref20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/cbdd.12834","article-title":"AVC pred: an integrated web server for prediction and design of antiviral compounds","volume":"89","author":"Qureshi","year":"2017","journal-title":"Chem Biol Drug Des"},{"issue":"8","key":"2022031506300914700_ref21","first-page":"80","article-title":"DeepTox: toxicity prediction using deep learning","volume":"3","author":"Mayr","year":"2016","journal-title":"Front Environ Sci"},{"issue":"1","key":"2022031506300914700_ref22","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1021\/acs.jmedchem.6b01611","article-title":"Profiling prediction of kinase inhibitors: toward the virtual assay","volume":"60","author":"Merget","year":"2017","journal-title":"J Med Chem"},{"issue":"11","key":"2022031506300914700_ref23","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1021\/ci400466r","article-title":"Heterogeneous classifier fusion for ligand-based virtual screening: or, how decision making by committee can be a good thing","volume":"53","author":"Riniker","year":"2013","journal-title":"J Chem Inf Model"},{"issue":"6","key":"2022031506300914700_ref24","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/cmdc.201700180","article-title":"Kinome-wide profiling prediction of small molecules","volume":"13","author":"Sorgenfrei","year":"2018","journal-title":"ChemMedChem"},{"issue":"1","key":"2022031506300914700_ref25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1021\/ci00057a005","article-title":"SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules","volume":"28","author":"Weininger","year":"1988","journal-title":"J Chem Inf Comput Sci"},{"issue":"2","key":"2022031506300914700_ref26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1021\/ci00062a008","article-title":"SMILES. 2. Algorithm for generation of unique SMILES notation","volume":"29","author":"Weininger","year":"1989","journal-title":"J Chem Inf Comput Sci"},{"issue":"6","key":"2022031506300914700_ref27","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1021\/ci010132r","article-title":"Reoptimization of MDL keys for use in drug discovery","volume":"42","author":"Durant","year":"2002","journal-title":"J Chem Inf Comput Sci"},{"key":"2022031506300914700_ref28","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ymeth.2014.08.005","article-title":"Molecular fingerprint similarity search in virtual screening","volume":"71","author":"Cereto-Massagu\u00e9","year":"2015","journal-title":"Methods"},{"issue":"1","key":"2022031506300914700_ref29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1748-7188-5-9","article-title":"A tree-based method for the rapid screening of chemical fingerprints","volume":"5","author":"Kristensen","year":"2010","journal-title":"Algorithms Mol Biol"},{"issue":"5","key":"2022031506300914700_ref30","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1021\/ci0498719","article-title":"Similarity searching of chemical databases using atom environment descriptors (MOLPRINT 2D): evaluation of performance","volume":"44","author":"Bender","year":"2004","journal-title":"J Chem Inf Comput Sci"},{"issue":"1","key":"2022031506300914700_ref31","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1021\/ci034207y","article-title":"Molecular similarity searching using atom environments, information-based feature selection, and a Na\u00efve Bayesian classifier","volume":"44","author":"Bender","year":"2004","journal-title":"J Chem Inf Comput Sci"},{"issue":"2","key":"2022031506300914700_ref32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1021\/c160017a018","article-title":"The generation of a unique machine description for chemical structures-a technique developed at chemical abstracts service","volume":"5","author":"Morgan","year":"1965","journal-title":"J Chem Doc"},{"issue":"4","key":"2022031506300914700_ref33","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1021\/ci030285+","article-title":"Design and evaluation of a molecular fingerprint involving the transformation of property descriptor values into a binary classification scheme","volume":"43","author":"Xue","year":"2003","journal-title":"J Chem Inf Comput Sci"},{"issue":"5","key":"2022031506300914700_ref34","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1021\/ci100050t","article-title":"Extended-connectivity fingerprints","volume":"50","author":"Rogers","year":"2010","journal-title":"J Chem Inf Model"},{"key":"2022031506300914700_ref35","article-title":"An overview of gradient descent optimization algorithms","author":"Ruder","year":"2016"},{"issue":"5","key":"2022031506300914700_ref36","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1540-6261.1996.tb05222.x","article-title":"Momentum strategies","volume":"51","author":"Chan","year":"1996","journal-title":"J Financ"},{"issue":"8","key":"2022031506300914700_ref37","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1109\/TAC.2004.832203","article-title":"Cooperative control of mobile sensor networks: adaptive gradient climbing in a distributed environment","volume":"49","author":"Ogren","year":"2004","journal-title":"IEEE Trans Automatic Control"},{"issue":"D1","key":"2022031506300914700_ref38","doi-asserted-by":"crossref","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","article-title":"ChEMBL: a large-scale bioactivity database for drug discovery","volume":"40","author":"Gaulton","year":"2012","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2022031506300914700_ref39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1021\/acs.jcim.7b00616","article-title":"Mol2vec: unsupervised machine learning approach with chemical intuition","volume":"58","author":"Jaeger","year":"2018","journal-title":"J Chem Inf Model"},{"issue":"3","key":"2022031506300914700_ref40","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1063\/1.882538","article-title":"Obituary: Ernst Ising","volume":"52","author":"Stutz","year":"1999","journal-title":"Phys Today"},{"issue":"4","key":"2022031506300914700_ref41","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1590\/S0103-97332000000400003","article-title":"Ernst Ising 1900-1998","volume":"30","author":"Kobe","year":"2000","journal-title":"Braz J Phys"},{"key":"2022031506300914700_ref42","doi-asserted-by":"crossref","first-page":"115892","DOI":"10.1016\/j.bmc.2020.115892","article-title":"Synthesis and evaluation of new phenyl acrylamide derivatives as potent non-nucleoside anti-HBV agents","volume":"29","author":"Gu","year":"2021","journal-title":"Bioorg Med Chem"},{"key":"2022031506300914700_ref43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejmech.2019.05.014","article-title":"Assessment of quinazolinone derivatives as novel non-nucleoside hepatitis B virus inhibitors","volume":"176","author":"Qiu","year":"2019","journal-title":"Eur J Med Chem"},{"key":"2022031506300914700_ref44","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ejmech.2017.12.042","article-title":"Design, synthesis and evaluation of novel phenyl propionamide derivatives as non-nucleoside hepatitis B virus inhibitors","volume":"144","author":"Qiu","year":"2018","journal-title":"Eur J Med Chem"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/23\/2\/bbab593\/42805068\/bbab593.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/23\/2\/bbab593\/42805068\/bbab593.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T06:36:03Z","timestamp":1647326163000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/doi\/10.1093\/bib\/bbab593\/6513448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,21]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3,10]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbab593","relation":{},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"value":"1467-5463","type":"print"},{"value":"1477-4054","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,3]]},"published":{"date-parts":[[2022,1,21]]},"article-number":"bbab593"}}